NIAID Data Sharing Recommendations

Guidance for NIAID Researchers

What data types should be shared?

NIAID expects researchers to comply with the NIH DMS policy. Scientific data, defined as all data necessary to replicate research findings regardless of whether the data are used to support scientific papers, must be shared. Data types may include, but are not limited to, genomic, transcriptomic, imaging, proteomics, metabolomics, immunological, flow cytometry, protein structures, and clinical data from human research participants generated during research projects and/or clinical trials. Data and metadata associated with funded research should be shared using common data standards, when possible.

However, not all data must be shared, including data resulting from calibration or preliminary analyses. Any ethical, legal, and/or technical factors that may affect sharing may be detailed in the Data Management and Sharing (DMS) Plan. See NIH guidance for additional details.

NIAID expects that researchers share de-identified human research participant-level data from NIAID-funded or conducted clinical trials through controlled access data platforms, including accessclinicaldata@NIAID, dbGaP, and TBPortals. Registration of studies on ClinicalTrials.gov will not be sufficient. Guidance is available on Protecting Participant Privacy When Sharing Scientific Data.

What is metadata?

Metadata is additional labeling of your data. This “data about data” describes data contents and structure. It also makes research data “discoverable” by enabling links to publications, other data, workflows or analysis pipelines, and funding information. Including metadata allows other researchers to interpret and reuse your data and prevents misuse, misinterpretation, and confusion.

The exact metadata or other associated documentation will vary by scientific area, study design, the type of data collected, and characteristics of the dataset. Metadata or other information associated with research data may include the methodology and procedures used to collect the data, data labels, definitions of variables, and any other information necessary to reproduce and understand the data.

Where do I share data from NIAID-funded or conducted research?

NIAID encourages the use of established domain-specific repositories for data sharing to support effective data discovery, access, and reuse. To select a repository for sharing data, review the list of NIH-Supported Data Sharing Resources, including NIAID-preferred repositories. When domain-specific repositories are not available, NIAID encourages researchers to share data via widely used generalist repositories. Read more about selecting a data repository.

It is common practice for researchers to share data as supplementary material to journal articles. However, making data available solely through publications, supplemental material, etc. is not compliant with NIAID expectations for data sharing.

When do I share data from NIAID-funded or conducted research?

The NIH DMS policy requires data sharing at the time of publication or at the end of the performance period, whichever comes first. NIAID strongly encourages scientific data to be shared as rapidly as possible. All scientific data generated by a study, including data beyond what used to support a publication, should be shared before the end of the performance period.

Human and non-human genomic data subject to the Genomic Data Sharing (GDS) policy must still comply with the GDS policy timeline expectations for data submission and sharing. To determine if your research is subject to the GDS policy, please review when the GDS policy applies . 

In some instances, data sharing before publication or the end of the performance period may be warranted, such as during public health emergencies. See NIH guidance  for details on data submission and sharing timelines. 

How do I develop a DMS Plan? 

Under the DMS policy, NIH expects investigators and institutions to: 

1. Following the NIH DMS policy expectations, prepare a DMS Plan using the updated template without modification.
2. Submit a DMS Plan when applying for funding.
3. Budget for sharing and management of scientific data. 
4. Comply with the approved DMS Plan.

Before you apply for NIAID funding, determine if your application falls under the DMS policy using resources available on Research Covered by the 2023 DMS policy . If your application is subject to the Genomic Data Sharing policy, your DMS Plan should address genomic data considerations.

You can find more information on the steps for developing and submitting a DMS Plan in NIAID’s Data Management and Sharing for Grants SOP. 

Credit: iStock

Resources for Sharing and Accessing Data 

The following resources can help NIAID researchers with data sharing and access in controlled-access, NIH-supported repositories. 

Genomic Program Administrators (GPAs)

The NIAID Genomic Program Administrators (GPAs) assist investigators with study registration and data submission to controlled-access repositories, such as dbGaP, and serve as experts on the Genomic Data Sharing (GDS) policy for NIAID. Divisional GPAs provide support to investigators funded by or within the NIAID divisions, with assistance from the overall NIAID GPA in the Office of Data Science and Emerging Technologies.

Principal Investigators should direct questions related to data management, sharing, and NIH policies to their Program Officers (POs). Questions from POs on these topics should be directed to their divisional GPA or the overall NIAID GPA.

Data Access Committee (DAC)

The NIAID Data Access Committee (DAC) provides guidance and oversight of controlled-access data housed within NIH designated repositories, including dbGaP and accessclinicaldata@NIAID. Learn more about requesting access for these and other NIH-funded repositories from the NIH's Accessing Scientific Data page and How to Request and Access Datasets from dbGaP page.

We encourage controlled access data repositories that host NIAID data to use the NIAID DAC for review of their Data Access Requests. Please contact NIAID DAC with any questions.